Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer.

Huang YH, Chang CY, Kuo YZ, Fang WY, Kao HY, Tsai ST, Wu LW.

Cancer Sci. 2019 Sep;110(9):2783-2793. doi: 10.1111/cas.14135. Epub 2019 Aug 2.

2.

Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.

Tsujikawa T, Yaguchi T, Ohmura G, Ohta S, Kobayashi A, Kawamura N, Fujita T, Nakano H, Shimada T, Takahashi T, Nakao R, Yanagisawa A, Hisa Y, Kawakami Y.

Int J Cancer. 2013 Jun 15;132(12):2755-66. doi: 10.1002/ijc.27966. Epub 2012 Dec 17.

3.

Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.

Chakraborty T, Bose A, Barik S, Goswami KK, Banerjee S, Goswami S, Ghosh D, Roy S, Chakraborty K, Sarkar K, Baral R.

Immunotherapy. 2011 Aug;3(8):949-69. doi: 10.2217/imt.11.81.

PMID:
21843083
4.

Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.

Wang XQ, Zhou WJ, Luo XZ, Tao Y, Li DJ.

Hum Reprod. 2017 Jun 1;32(6):1304-1317. doi: 10.1093/humrep/dex067.

PMID:
28383711
5.

IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis.

Araujo-Pires AC, Vieira AE, Francisconi CF, Biguetti CC, Glowacki A, Yoshizawa S, Campanelli AP, Trombone AP, Sfeir CS, Little SR, Garlet GP.

J Bone Miner Res. 2015 Mar;30(3):412-22. doi: 10.1002/jbmr.2376.

6.

CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.

Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, Sugai H, Fujii H.

Int J Cancer. 2008 May 15;122(10):2286-93. doi: 10.1002/ijc.23392.

7.

Prognostic significance and mechanism of Treg infiltration in human brain tumors.

Jacobs JF, Idema AJ, Bol KF, Grotenhuis JA, de Vries IJ, Wesseling P, Adema GJ.

J Neuroimmunol. 2010 Aug 25;225(1-2):195-9. doi: 10.1016/j.jneuroim.2010.05.020.

PMID:
20537408
8.

Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.

Kimpfler S, Sevko A, Ring S, Falk C, Osen W, Frank K, Kato M, Mahnke K, Schadendorf D, Umansky V.

J Immunol. 2009 Nov 15;183(10):6330-7. doi: 10.4049/jimmunol.0900609. Epub 2009 Oct 19.

9.

CCR4 dependent migration of Foxp3+ Treg cells to skin grafts and draining lymph nodes is implicated in enhanced graft survival in CD200tg recipients.

Yu K, Chen Z, Khatri I, Gorczynski RM.

Immunol Lett. 2011 Dec 30;141(1):116-22. doi: 10.1016/j.imlet.2011.09.002. Epub 2011 Sep 17.

PMID:
21945175
10.

Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma.

Sun W, Li WJ, Wei FQ, Wong TS, Lei WB, Zhu XL, Li J, Wen WP.

Oncotarget. 2016 Jun 21;7(25):37714-37727. doi: 10.18632/oncotarget.9265.

11.

CCL1 is a major regulatory T cell attracting factor in human breast cancer.

Kuehnemuth B, Piseddu I, Wiedemann GM, Lauseker M, Kuhn C, Hofmann S, Schmoeckel E, Endres S, Mayr D, Jeschke U, Anz D.

BMC Cancer. 2018 Dec 20;18(1):1278. doi: 10.1186/s12885-018-5117-8.

12.

Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor.

Benevides L, Cardoso CR, Tiezzi DG, Marana HR, Andrade JM, Silva JS.

Eur J Immunol. 2013 Jun;43(6):1518-28. doi: 10.1002/eji.201242951. Epub 2013 May 16.

13.

Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer.

Li YQ, Liu FF, Zhang XM, Guo XJ, Ren MJ, Fu L.

PLoS One. 2013 Oct 4;8(10):e76379. doi: 10.1371/journal.pone.0076379. eCollection 2013.

14.

Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.

Riezu-Boj JI, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, Echeverria I, Sarobe P, Herrero I, Sangro B, Prieto J, Lasarte JJ.

J Hepatol. 2011 Mar;54(3):422-31. doi: 10.1016/j.jhep.2010.07.014. Epub 2010 Sep 26.

15.

Astrocyte elevated gene-1 promotes tumour growth and invasion by inducing EMT in oral squamous cell carcinoma.

Wang Y, Wang T, Sun Y, Sun W, Wang X.

Sci Rep. 2017 Nov 13;7(1):15447. doi: 10.1038/s41598-017-15805-8.

16.

Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.

Zen Y, Liberal R, Nakanuma Y, Heaton N, Portmann B.

J Hepatol. 2013 Nov;59(5):1059-64. doi: 10.1016/j.jhep.2013.06.016. Epub 2013 Jun 25.

PMID:
23811304
17.
18.

Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.

Viney JM, Andrew DP, Phillips RM, Meiser A, Patel P, Lennartz-Walker M, Cousins DJ, Barton NP, Hall DA, Pease JE.

J Immunol. 2014 Apr 1;192(7):3419-27. doi: 10.4049/jimmunol.1300232. Epub 2014 Feb 21.

19.

Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis.

Maolake A, Izumi K, Shigehara K, Natsagdorj A, Iwamoto H, Kadomoto S, Takezawa Y, Machioka K, Narimoto K, Namiki M, Lin WJ, Wufuer G, Mizokami A.

Oncotarget. 2017 Feb 7;8(6):9739-9751. doi: 10.18632/oncotarget.14185.

20.

Critical role of CCL22/CCR4 axis in the maintenance of immune homeostasis during apoptotic cell clearance by splenic CD8α(+) CD103(+) dendritic cells.

Hao S, Han X, Wang D, Yang Y, Li Q, Li X, Qiu CH.

Immunology. 2016 Jun;148(2):174-86. doi: 10.1111/imm.12596. Epub 2016 Mar 30.

Supplemental Content

Support Center